WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009061934) USE OF PRODRUGS OF GABA B AGONISTS FOR TREATING NEUROPATHIC AND MUSCULOSKELETAL PAIN
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/061934    International Application No.:    PCT/US2008/082659
Publication Date: 14.05.2009 International Filing Date: 06.11.2008
IPC:
A61K 31/195 (2006.01), A61P 29/00 (2006.01)
Applicants: XENOPORT, INC. [US/US]; 3410 Central Expressway, Santa Clara, California 95051 (US) (For All Designated States Except US).
BENSON, Joseph C. III [US/US]; (US) (For US Only).
VIRSIK, Peter [US/US]; (US) (For US Only).
CANAFAX, Daniel M. [US/US]; (US) (For US Only)
Inventors: BENSON, Joseph C. III; (US).
VIRSIK, Peter; (US).
CANAFAX, Daniel M.; (US)
Agent: WORRALL, Timothy A.; 370 Seventeenth Street, Suite 4700, Denver, Colorado 80202 (US)
Priority Data:
60/985,909 06.11.2007 US
Title (EN) USE OF PRODRUGS OF GABA B AGONISTS FOR TREATING NEUROPATHIC AND MUSCULOSKELETAL PAIN
(FR) UTILISATION DE PROMÉDICAMENTS D'AGONISTES DE GABA B POUR LE TRAITEMENT DE DOULEUR NEUROPATHIQUE ET MUSCULO-SQUELETTIQUE
Abstract: front page image
(EN)Methods of treating neuropathic pain, musculoskeletal pain, and back spasm associated with musculoskeletal pain in a patient comprising orally administering a therapeutically effective dose of a prodrug of a GABAB agonist having a high oral bioavailability of the corresponding GABAB agonist are disclosed.
(FR)La présente invention concerne des procédés de traitement de douleur neuropathique, de douleur musculo-squelettique, et de spasme dorsal associé à la douleur musculo-squelettique chez un patient comprenant l'administration orale d'une dose thérapeutiquement efficace d'un promédicament d'un agoniste de GABAB, ayant une biodisponibilité orale élevée de l'agoniste GABAB correspondant.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)